Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Discovery
Cancer Discovery
  • Home
  • About
    • The Journal
    • AACR Journals
    • Journal Sections
    • Subscriptions
    • Reviewing
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Collections
      • COVID-19 & Cancer Resource Center
      • Clinical Trials
      • Immuno-oncology
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
    • Journal Press Releases
  • COVID-19
  • Webinars
  • 10th Anniversary
  • Search More

    Advanced Search

Research Watch

Deregulation of IGF1R Proteostasis Promotes Myeloid Transformation

DOI: 10.1158/2159-8290.CD-RW2016-004 Published February 2016
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading
  • Major finding: Mice lacking AIRAPL develop myeloproliferative neoplasms caused by disrupted IGF1 signaling.

  • Mechanism: AIRAPL binds to pro-IGF1R and promotes its ubiquitination and proteasomal degradation.

  • Impact: IGF1R inhibitors may have promise as potential therapeutics to treat myeloproliferative neoplasms.

Figure1

Arsenite-inducible RNA-associated protein-like (AIRAPL; encoded by ZFAND2B) is an evolutionarily conserved endoplasmic reticulum protein known to regulate cellular proteostasis in Caenorhabditis elegans, but its function in mammals is unknown. Osorio and colleagues generated a Zfand2b−/− mouse, which has a number of defects including a shortened lifespan, progressive weight loss, splenomegaly due to extramedullary hematopoiesis and myeloid lineage expansion, elevated peripheral blood leukocytes, and increased myeloid cells that collectively recapitulate myeloproliferative neoplasms (MPN). Zfand2b−/− mice had increased expression and phosphorylation of IGF1R, and in vitro overexpression of AIRAPL led to a reduction in IGF1R levels that was reversible by proteasome inhibition, suggesting a mechanism of AIRAPL-mediated IGF1R regulation involving ubiquitination and degradation by the proteasome. Consistent with these findings, AIRAPL expression increased IGF1R monoubiquitination, and AIRAPL immunoprecipitated with proteasome and ER-associated degradation subunits. AIRAPL associated only with pro-IGF1R, and reduced the levels of mature IGF1R translocated out of the ER, indicating that AIRAPL modulates IGF1R levels by regulating the translocation and degradation of IGF1R. Igf1r haploinsufficiency or inhibition in Zfand2b−/− mice resulted in a reduction in the MPN phenotypes, supporting a role for IGF1R as a driver of MPN in Zfand2b−/− mice. The mouse data were validated in human MPNs, which did not express AIRAPL and exhibited increased IGF1R expression. Increased IGF1R expression associated with AIRAPL loss was similarly observed in a MPN mouse model (Jak2V617F), and in acute myeloid leukemia cell lines with the JAK2V617 mutation, IGF1R inhibition induced growth arrest, whereas overexpression increased proliferation. Mechanistically, ZFAND2B expression was found to be regulated in MPNs by the miRNA miR-125a-3p, and the reduction of this miRNA resulted in a reversion of the myeloproliferative phenotype. Altogether, these findings indicate that AIRAPL acts as a tumor suppressor in myeloid cells by negatively regulating IGF1R and provide a rationale for evaluation of IGF1R inhibitors in patients with MPNs.

Osorio FG, Soria-Valles C, Santiago-Fernández O, Bernal T, Mittelbrunn M, Colado E, et al. Loss of the proteostasis factor AIRAPL causes myeloid transformation by deregulating IGF-1 signaling. Nat Med 2016;22:91–6.

Notes

Note: Research Watch is written by Cancer Discovery editorial staff. Readers are encouraged to consult the original articles for full details. For more Research Watch, visit Cancer Discovery online at http://cancerdiscovery.aacrjournals.org/content/early/by/section.

  • ©2016 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Discovery: 6 (2)
February 2016
Volume 6, Issue 2
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Discovery article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Deregulation of IGF1R Proteostasis Promotes Myeloid Transformation
(Your Name) has forwarded a page to you from Cancer Discovery
(Your Name) thought you would be interested in this article in Cancer Discovery.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Deregulation of IGF1R Proteostasis Promotes Myeloid Transformation
Cancer Discov February 1 2016 (6) (2) 120; DOI: 10.1158/2159-8290.CD-RW2016-004

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Deregulation of IGF1R Proteostasis Promotes Myeloid Transformation
Cancer Discov February 1 2016 (6) (2) 120; DOI: 10.1158/2159-8290.CD-RW2016-004
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Notes
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Research Watch

  • Structures Identify Selpercatinib and Pralsetinib Resistance Mechanisms
  • Cryo-EM Structures Reveal Mechanism of Anticancer MCT1 Inhibitors
  • Computational Tool Characterizes Previously Unidentified Tumor Subtypes
Show more Research Watch

Hematologic Cancers

  • BET Inhibitors Target Blastic Plasmacytoid Dendritic Cell Neoplasms
Show more Hematologic Cancers
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • OnlineFirst
  • Current Issue
  • Past Issues

Info For

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Discovery

  • About the Journal
  • Editors
  • Journal Sections
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Discovery
eISSN: 2159-8290
ISSN: 2159-8274

Advertisement